Literature DB >> 8242261

Characterization of the adenosine receptors of the rat superior cervical ganglion.

G P Connolly1, T W Stone, F Brown.   

Abstract

1. Adenosine analogues caused hyperpolarization and inhibition of the depolarizing response to muscarine of the rat isolated superior cervical ganglion (SCG) measured by a 'grease gap' recording technique. The receptors mediating these responses have been characterized by use of a range of selective adenosine analogues and adenosine receptor antagonists. 2. In decreasing order of potency N6-cyclopentyladenosine (CPA), 2-chloroadenosine (2CA), adenosine, 2-phenylaminoadenosine (PAA), caused concentration-dependent hyperpolarizations whilst N6-(9-fluorenylmethyl)adenosine (PD 117,413) was inactive at up to 100 microM. 3. The order of potency of adenosine analogues in depressing depolarization caused by a submaximal concentration of muscarine (100 nM) was: CPA > R-PIA = 2CA > NECA > S-PIA > BZA > adenosine > PAA, where R- and S-PIA = R(-)- and S(+)-N6-(2-phenylisopropyl)adenosine, NECA = 5'N-ethylcarboxamidoadenosine and BZA = N6-benzyladenosine. PD 117,413 was inactive at concentrations up to 100 microM. The maximum inhibitions of the muscarine-induced depolarization by CPA, 2CA, NECA and BZA were similar. R-PIA, S-PIA and PAA produced similar maximal inhibitions which were significantly smaller than those produced by CPA. 4. Hyperpolarizations caused by adenosine were antagonized by the P1-purinoceptor selective antagonist 1,3-dimethyl-8-phenylxanthine (8PT) and by the selective A1-adenosine receptor antagonist, 1,3-dipropyl-8-(4-((2-aminoethyl)amino)carbonylmethyloxyphenyl++ +)xanthine (XAC). Hyperpolarizations caused by CPA, adenosine and PAA were antagonized by the A1-selective antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) but not by the A2-selective antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX). 5. Inhibition of the muscarinic-induced depolarization by CPA was antagonized by 8PT and DPCPXbut not by DMPX.6. It is concluded that the neurones of the rat SCG possess P1-purinoceptors of the Al-adenosine receptor subtype which mediate hyperpolarization and inhibition of depolarization caused by muscarine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242261      PMCID: PMC2175924          DOI: 10.1111/j.1476-5381.1993.tb13891.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  Adenosine antagonists.

Authors:  M Williams
Journal:  Med Res Rev       Date:  1989 Apr-Jun       Impact factor: 12.944

2.  Pharmacological analysis of the calcium-dependence of mu-receptor agonism.

Authors:  I G Dougall; P Leff
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.

Authors:  B K Trivedi; J A Bristol; R F Bruns; S J Haleen; R P Steffen
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

4.  3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs.

Authors:  T W Seale; K A Abla; M T Shamim; J M Carney; J W Daly
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

5.  Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow.

Authors:  J W Daly; W Padgett; R D Thompson; S Kusachi; W J Bugni; R A Olsson
Journal:  Biochem Pharmacol       Date:  1986-08-01       Impact factor: 5.858

6.  Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.

Authors:  D Ukena; M T Shamim; W Padgett; J W Daly
Journal:  Life Sci       Date:  1986-08-25       Impact factor: 5.037

7.  Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue.

Authors:  M Williams; M F Jarvis; M A Sills; J W Ferkany; A Braunwalder
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

8.  Definition of subclasses of adenosine receptors associated with adenylate cyclase: interaction of adenosine analogs with inhibitory A1 receptors and stimulatory A2 receptors.

Authors:  D Ukena; R A Olsson; J W Daly
Journal:  Can J Physiol Pharmacol       Date:  1987-03       Impact factor: 2.273

9.  Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo.

Authors:  B B Fredholm; K A Jacobson; B Jonzon; K L Kirk; Y O Li; J W Daly
Journal:  J Cardiovasc Pharmacol       Date:  1987-04       Impact factor: 3.105

10.  Apparent affinity of 1,3-dipropyl-8-cyclopentylxanthine for adenosine A1 and A2 receptors in isolated tissues from guinea-pigs.

Authors:  M G Collis; S M Stoggall; F M Martin
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

View more
  3 in total

1.  Structure-activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion.

Authors:  G P Connolly; P J Harrison
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

2.  Discrimination between UTP- and P2-purinoceptor-mediated depolarization of rat superior cervical ganglia by 4,4'-diisothiocyanatostilbene-2,2'- disulphonate (DIDS) and uniblue A.

Authors:  G P Connolly; P J Harrison
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

3.  Differentiation by pyridoxal 5-phosphate, PPADS and IsoPPADS between responses mediated by UTP and those evoked by alpha, beta-methylene-ATP on rat sympathetic ganglia.

Authors:  G P Connolly
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.